About this trial
Get With The Guidelines-Atrial Fibrillation is designed to assist hospital care teams in consistently providing the latest evidence-based treatment for their AFib patients. At the same time, it offers a means of monitoring the quality of AFib care in U.S. hospitals and building a database for continued research and further quality improvement.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Patients hospitalized with nonvalvular Atrial Fibrillation or Atrial Flutter
Disqualifiers
Patients who do not have nonvalvular Atrial Fibrillation or Atrial Flutter
Patients under 18 years of age
Patients not admitted as inpatients.
Patients on comfort care only
Trial population
The study population is patients with the diagnosis of nonvalvular Atrial Fibrillation or Atrial Flutter.
Trial design
Cohort
Other
Treatments tested in this trial
GWTG Atrial Fibrillation program
Other interventionEvidence based recommended therapies and counseling prior to hospital discharge.
Treatment groups
Trial outcomes
Primary outcomes
Cardiac Tamponade and/or Pericardiocentesis Following Ablation
Percent of patients with cardiac tamponade and/or pericardiocentesis occurring within 30 days following ablation procedure.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.